Article
Deep Learning-Enhanced 3D Imaging Unveils Semaglutide Impact on Cardiac Fibrosis
medRxiv · 2025 · Barrado-Ballestero, S.; Yttergren, S. T.; Hahn, M.; Rosenkilde, M. B.; Jensen, D. M.; Christensen, M.; Thisted, L.; Holmberg, H. L.; Teixeira, G.; Biering-Soerensen, T.; Salinas, C. G.; Roostalu, U.
Key facts
| Title | Deep Learning-Enhanced 3D Imaging Unveils Semaglutide Impact on Cardiac Fibrosis |
|---|---|
| First author | Barrado-Ballestero, S.; Yttergren, S. T.; Hahn, M.; Rosenkilde, M. B.; Jensen, D. M.; Christensen, M.; Thisted, L.; Holmberg, H. L.; Teixeira, G.; Biering-Soerensen, T.; Salinas, C. G.; Roostalu, U. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.02.25.640039 |
| Devices mentioned | K000534, K003865, K021512, K023296, K024098, K031824, K031879, K033009, K033185, K040782, K051890, K052982 and 32 more |
| Product codes mentioned | CDS, CEM, CGA, CGZ, CHL, DLJ, GKR, JIL, JIT, JIX, JJE, JJF and 35 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1